Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell - 9-MTH group results

Feb 13 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2018        Dec 31, 2017      Mar 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            806 mln             686 mln            1.17      
                 (+17.3 pct)         (-20.2 pct)       (+26.1 pct)  
  Operating     loss 587 mln        loss 772 mln      loss 757 mln  
  Recurring     loss 456 mln        loss 639 mln      loss 709 mln  
  Net           loss 430 mln        loss 652 mln      loss 709 mln  
  EPS           loss 6.37 yen      loss 10.32 yen    loss 11.09 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news